Prediction of infant drug exposure through breastfeeding: Population PK modeling and simulation of fluoxetine exposure

Clinical Pharmacology and Therapeutics

Volumn 89, Issue 6, 2011, Pages 830-836

  Panchaud, A ^a,b   Garcia Bournissen, F ^a   Csajka, C ^b,c,d   Kristensen, J H ^e   Taddio, A ^a   Ilett, K F ^e,f   Begg, E J ^g   Ito, S ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITY OF GENEVA   (Switzerland)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

^e KING EDWARD MEMORIAL HOSPITAL   (Australia)

^f UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^g UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE;

ADULT; ALLOMETRY; ARTICLE; BREAST FEEDING; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EXCRETION; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MILK; PERINATAL DRUG EXPOSURE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SIMULATION;

ADULT; AGE FACTORS; BREAST FEEDING; CHILD, PRESCHOOL; FEMALE; FLUOXETINE; FORECASTING; HUMANS; INFANT; INFANT, NEWBORN; MILK, HUMAN; NONLINEAR DYNAMICS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79956322717     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2011.23     Document Type: Article

References (40)

1. World Health Organization (WHO). The Optimal Duration of Exclusive Breastfeeding. Report of an Expert Consultation. (WHO/NHD/0 1.0 9., Geneva, Switzerland, 2002).
2. Kramer, M.S. & Kakuma, R. Optimal duration of exclusive breastfeeding. Cochrane Database Syst. Rev. 1, CD003517 (2002).
3. Health Canada. Exclusive breastfeeding duration. 2004 Health Canada recommendation. Ottawa: Health Canada, 2004.
4. Gartner, L.M. et al. Breastfeeding and the use of human milk. Pediatrics 115, 496-506 (2005).
5. Ito, S. Drug therapy for breast-feeding women. N. Engl. J. Med. 343, 118-126 (2000).
6. McNamara, P.J. & Abbassi, M. Neonatal exposure to drugs in breast milk. Pharm. Res. 21, 555-566 (2004). (Pubitemid 38457277)
7. Koren, G., Cairns, J., Chitayat, D., Gaedigk, A. & Leeder, S.J. Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother. Lancet 368, 704 (2006). (Pubitemid 44223697)
8. Madadi, P., Shirazi, F., Walter, F.G. & Koren, G. Establishing causality of CNS depression in breastfed infants following maternal codeine use. Paediatr. Drugs 10, 399-404 (2008).
9. Ito, S., Koren, G. & Einarson, T.R. Maternal noncompliance with antibiotics during breastfeeding. Ann. Pharmacother. 27, 40-42 (1993). (Pubitemid 23024806)
10. Ito, S., Lieu, M., Chan, W. & Koren, G. Continuing drug therapy while breastfeeding. Part 1. Common misconceptions of patients. Can. Fam. Physician 45, 897-899 (1999).
11. Koren, G., Moretti, M. & Ito, S. Continuing drug therapy while breastfeeding. Part 2. Common misconceptions of physicians. Can. Fam. Physician 45, 1173-1175 (1999).
12. Kristensen, J.H., Ilett, K.F., Hackett, L.P., Yapp, P., Paech, M. & Begg, E.J. Distribution and excretion of fuoxetine and norfuoxetine in human milk. Br. J. Clin. Pharmacol. 48, 521-527 (1999). (Pubitemid 29454232)
13. Taddio, A., Ito, S. & Koren, G. Excretion of fuoxetine and its metabolite, Norfuoxetine, In human breast milk. J. Clin. Pharmacol. 36, 42-47 (1996). (Pubitemid 26058809)
14. Altamura, A.C., Moro, A.R. & Percudani, M. Clinical pharmacokinetics of fuoxetine. Clin. Pharmacokinet. 26, 201-214 (1994).
15. Berle, J.O., Steen, V.M., Aamo, T.O., Breilid, H., Zahlsen, K. & Spigset, O. Breastfeeding during maternal antidepressant treatment with serotonin reuptake inhibitors: infant exposure, Clinical symptoms, And cytochrome p450 genotypes. J. Clin. Psychiatry 65, 1228-1234 (2004).
16. Burch, K.J. & Wells, B.G. Fluoxetine/norfuoxetine concentrations in human milk. Pediatrics 89, 676-677 (1992).
17. Heikkinen, T., Ekblad, U., Palo, P. & Laine, K. Pharmacokinetics of fuoxetine and norfuoxetine in pregnancy and lactation. Clin. Pharmacol. Ther. 73, 330-337 (2003). (Pubitemid 36403593)
18. Hendrick, V. et al. Fluoxetine and norfuoxetine concentrations in nursing infants and breast milk. Biol. Psychiatry 50, 775-782 (2001). (Pubitemid 33086765)
19. Isenberg, K.E. Excretion of fuoxetine in human breast milk. J. Clin. Psychiatry 51, 169 (1990). (Pubitemid 20129744)
20. Suri, R., Stowe, Z.N., Hendrick, V., Hostetter, A., Widawski, M. & Altshuler, L.L. Estimates of nursing infant daily dose of fuoxetine through breast milk. Biol. Psychiatry 52, 446-451 (2002). (Pubitemid 35266736)
21. Yoshida, K., Smith, B., Craggs, M. & Kumar, R.C. Fluoxetine in breast-milk and developmental outcome of breast-fed infants. Br. J. Psychiatry 172, 175-178 (1998).
22. Rampono, J. et al. Placental transfer of SSRI and SNRI antidepressants and efects on the neonate. Pharmacopsychiatry 42, 95-100 (2009).
23. Weissman, A.M. et al. Pooled analysis of antidepressant levels in lactating mothers, Breast milk, And nursing infants. Am. J. Psychiatry 161, 1066-1078 (2004). (Pubitemid 38735993)
24. Ito, S. & Lee, A. Drug excretion into breast milk-overview. Adv. Drug Deliv. Rev. 55, 617-627 (2003).
25. Garcia-Bournissen, F., Feig, D.S. & Koren, G. Maternal-fetal transport of hypoglycaemic drugs. Clin. Pharmacokinet. 42, 303-313 (2003). (Pubitemid 36433873)
26. Ilett, K.F. et al. Use of a sparse sampling study design to assess transfer of tramadol and its O-desmethyl metabolite into transitional breast milk. Br. J. Clin. Pharmacol. 65, 661-666 (2008). (Pubitemid 351535096)
27. Salman, S., Sy, S.K., Ilett, K.F., Page-Sharp, M. & Paech, M.J. Population pharmacokinetic modeling of tramadol and its O-desmethyl metabolite in plasma and breast milk. Eur. J. Clin. Pharmacol. (2011); e-pub ahead of print 11 March 2011.
28. Lubetzky, R., Mimouni, F.B., Dollberg, S., Salomon, M. & Mandel, D. Consistent circadian variations in creamatocrit over the frst 7 weeks of lactation: a longitudinal study. Breastfeed. Med. 2, 15-18 (2007). (Pubitemid 46766389)
29. Saarela, T., Kokkonen, J. & Koivisto, M. Macronutrient and energy contents of human milk fractions during the frst six months of lactation. Acta Paediatr. 94, 1176-1181 (2005). (Pubitemid 41510607)
30. Anderson, B.J. & Holford, N.H. Mechanism-based concepts of size and maturity in pharmacokinetics. Annu. Rev. Pharmacol. Toxicol. 48, 303-332 (2008). (Pubitemid 351738156)
31. Tod, M., Jullien, V. & Pons, G. Facilitation of drug evaluation in children by population methods and modelling. Clin. Pharmacokinet. 47, 231-243 (2008). (Pubitemid 351367434)
32. Mahmood, I. Theoretical versus empirical allometry: Facts behind theories and application to pharmacokinetics. J. Pharm. Sci. 99, 2927-2933 (2010).
33. Lindbom, L., Pihlgren, P., Jonsson, E.N. & jonsson, N. PsN-Toolkit-a collection of computer intensive statistical methods for non-linear mixed efect modeling using NONMEM. Comput. Methods Programs Biomed. 79, 241-257 (2005). (Pubitemid 41196689)
34. Kent, J.C., Mitoulas, L., Cox, D.B., Owens, R.A. & Hartmann, P.E. Breast volume and milk production during extended lactation in women. Exp. Physiol. 84, 435-447 (1999). (Pubitemid 29150031)
35. Kent, J.C., Mitoulas, L.R., Cregan, M.D., Ramsay, D.T., Doherty, D.A. & Hartmann, P.E. Volume and frequency of breastfeedings and fat content of breast milk throughout the day. Pediatrics 117, E387-e395 (2006). (Pubitemid 46063177)
36. Bennett P.N. Use of the monographs on drugs. In Drugs and Human Lactation 2nd edn. (ed. Bennett P.N.) 67-74 (Elsevier, Amsterdam, Netherlands, 1996).
37. Allegaert, K. et al. O-demethylation of tramadol in the frst months of life. Eu r. J. Clin. Pharmacol. 61, 837-842 (2005). (Pubitemid 41720272)
38. Allegaert, K. et al. Tramadol disposition in the very young: an attempt to assess in vivo cytochrome P-450 2D6 activity. Br. J. Anaesth. 95, 231-239 (2005). (Pubitemid 41487151)
39. Blake, M.J. et al. Ontogeny of dextromethorphan O- and N-demethylation in the frst year of life. Clin. Pharmacol. Ther. 81, 510-516 (2007). (Pubitemid 46452306)
40. Johnson, T.N., Tucker, G.T. & Rostami-Hodjegan, A. Development of CYP2D6 and CYP3A4 in the frst year of life. Clin. Pharmacol. Ther. 83, 670-671 (2008). (Pubitemid 351556011)